+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices

Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices

International Journal of Gynecological Pathology 5(3): 235-241

Levonorgestrel-releasing intrauterine devices (IUD) were inserted in 92 women. Endometrial biopsies were taken between 3 months and 7 years after these insertions. Intrauterine release of levonorgestrel resulted in endometrial glandular atrophy and decidualized stroma. Inflammation and necrosis were also seen as local signs of IUD use. The biopsies were similar regardless of the duration of IUD use. Endometrial morphology returned to normal in biopsy specimens taken 1-3 months after IUD removal.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 040016243

Download citation: RISBibTeXText

PMID: 3093395

DOI: 10.1097/00004347-198609000-00005

Related references

The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 139(2): 169-175, 2008

Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices. Acta Europaea Fertilitatis 18(2): 137-140, 1987

Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial. Gynecologic Oncology 114(3): 452-456, 2009

Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up. Maturitas 57(2): 210-213, 2007

Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstetrics and Gynecology 77(2): 261-264, 1991

Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system. Human Reproduction 21(5): 1129-1134, 2006

Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Contraception 91(4): 280-283, 2015

Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception 91(4): 274-279, 2015

Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. Fertility and Sterility 39(2): 187-192, 1983

Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone. Acta Obstetricia Et Gynecologica Scandinavica. 77(7): 758-763,., 1998

Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system. Contraception 80(1): 84-89, 2009

Long term use of the levonorgestrel releasing intrauterine device. International Journal of Gynecology & Obstetrics (ABSTR SUPPL): 271, 1991

Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 75(6 Suppl): S161-S166, 2007

Long-term experience of a levonorgestrel-releasing intrauterine system. European Journal of Contraception and Reproductive Health Care 1(4): 319-323, 1996

A case of endometrial carcinoma in a long-term Levonorgestrel Intrauterine System (LNG 52 mg-IUS) user. Post Reproductive Health 23(1): 13-14, 2017